Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review Jeffrey M Peppercorn, Jane C Weeks, E Francis Cook, Steven Joffe Departments of Medical Oncology (J M Peppercorn MD, J C Weeks MD), and Pediatric Oncology (S Joffe MD), Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston (J M Peppercorn, J C Weeks, Prof E F Cook ScD); Department of Medicine, Children's Hospital, Boston (S Joffe); and Harvard School of Public Health, Boston (E F Cook) Correspondence to: Dr Steven Joffe, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA (e-mail:steven_joffe@dfci.harvard.edu) Summary Background Many oncologists believe that patients with cancer who enrol in clinical trials have better outcomes than those who do not enrol. We aimed to assess the empirical evidence that such a trial effect exists. Methods We developed a conceptual framework for comparison of trial and non-trial patients. We then did a comprehensive literature search to identify studies that compared outcomes between these groups. We critically evaluated these studies to assess whether they provide valid and generalisable support for a trial effect. Findings We identified 26 comparisons, from 24 published articles, of outcomes among cancer patients enrolled and not enrolled in clinical trials. 21 comparisons used retrospective cohort designs. 14 comparisons provided some evidence that patients enrolled in trials have improved outcomes. However, strategies to control for potential confounding factors were inconsistent and frequently inadequate. Only eight comparisons restricted non-trial patients to those meeting trial eligibility criteria. Of these, three noted better outcomes in trial patients than in non-trial patients. Children with cancer, patients with haematological malignant disease, and patients treated before 1986 were disproportionately represented in positive studies. Interpretation Despite widespread belief that enrolment in clinical trials leads to improved outcomes in patients with cancer, there are insufficient data to conclude that such a trial effect exists. Until such data are available, patients with cancer should be encouraged to enrol in clinical trials on the basis of trials' unquestioned role in improving treatment for future patients. Lancet 2004; 363: 263-70 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.